Ovid Therapeutics, based in New York, NY, is a pioneering biopharmaceutical company dedicated to improving the lives of individuals and families affected by neurological diseases. With a focus on conquering epilepsies and brain conditions, Ovid is developing targeted small molecule therapies to reduce seizures and enhance safety and tolerability.
Driven by a science-driven and patient-focused mission, Ovid aims to deliver innovative medicines that offer new possibilities and better days for those living with epilepsies and brain conditions. Through unique compounds and potential best-in-class mechanisms of action, the company aspires to lead the way in developing effective treatments and potentially altering the course of disease.
Generated from the website